214 related articles for article (PubMed ID: 3616444)
41. [Behçet's disease].
Aouba A
Rev Prat; 2008 Mar; 58(5):533-40. PubMed ID: 18524110
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome.
BenEzra D; Cohen E; Chajek T; Friedman G; Pizanti S; de Courten C; Harris W
Transplant Proc; 1988 Jun; 20(3 Suppl 4):136-43. PubMed ID: 3381269
[TBL] [Abstract][Full Text] [Related]
43. Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease.
Saricaoglu H; Yilmaz M; Karkucak M; Ozturk HZ; Yakut T; Gulten T; Baskan EB; Aydogan K; Dilek K
Genet Mol Res; 2011 Jan; 10(1):1-6. PubMed ID: 21218380
[TBL] [Abstract][Full Text] [Related]
44. Acute myocardial infarction and ascending aortic aneurysm in a child with Behçet's disease.
Zhuang J; Wang S; Zhang Z; Zeng S; Shi Y; Nong S
Turk J Pediatr; 2008; 50(1):81-5. PubMed ID: 18365599
[TBL] [Abstract][Full Text] [Related]
45. [Clinico-immunological study of 6 cases of Behçet's disease].
Silingardi V; Montemurno C; Venezia L; Franceschi C; Riva PC; Emilia G; Masi M; Merelli E; Torelli G; Licastro F; Fantini MP; Federico M
Minerva Med; 1979 Nov; 70(48):3269-84. PubMed ID: 390423
[TBL] [Abstract][Full Text] [Related]
46. Clinical and immunological effects of azithromycin in Behçet's disease.
Mumcu G; Ergun T; Elbir Y; Eksioglu-Demiralp E; Yavuz S; Atalay T; Direskeneli H
J Oral Pathol Med; 2005 Jan; 34(1):13-6. PubMed ID: 15610401
[TBL] [Abstract][Full Text] [Related]
47. Neuro-Behçet's syndrome presenting with features mimicking acute tuberculous meningitis.
Ural O; Genç E; Demir NA; Balci M; Genç BO
Int J Infect Dis; 2009 Jul; 13(4):e141-4. PubMed ID: 18990598
[TBL] [Abstract][Full Text] [Related]
48. Behçet's disease.
Yesudian PD; Edirisinghe DN; O'Mahony C
Int J STD AIDS; 2007 Apr; 18(4):221-7. PubMed ID: 17509169
[TBL] [Abstract][Full Text] [Related]
49. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
[TBL] [Abstract][Full Text] [Related]
50. Clinical features of Behçet's disease in children.
Borlu M; Ukşal U; Ferahbaş A; Evereklioglu C
Int J Dermatol; 2006 Jun; 45(6):713-6. PubMed ID: 16796634
[TBL] [Abstract][Full Text] [Related]
51. Treatment of Behçet's disease--an update.
Kaklamani VG; Kaklamanis PG
Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
[TBL] [Abstract][Full Text] [Related]
52. Long-term efficacy and safety of infliximab in the treatment of Behçet's disease.
Capella MJ; Foster CS
Ocul Immunol Inflamm; 2012 Jun; 20(3):198-202. PubMed ID: 22486265
[TBL] [Abstract][Full Text] [Related]
53. Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study.
Karincaoglu Y; Borlu M; Toker SC; Akman A; Onder M; Gunasti S; Usta A; Kandi B; Durusoy C; Seyhan M; Utas S; Saricaoglu H; Ozden MG; Uzun S; Tursen U; Cicek D; Donmez L; Alpsoy E
J Am Acad Dermatol; 2008 Apr; 58(4):579-84. PubMed ID: 18045733
[TBL] [Abstract][Full Text] [Related]
54. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
[TBL] [Abstract][Full Text] [Related]
55. Behçet's disease and immunosuppressive treatment. Our personal experience.
Bietti GB; Cerulli L; Pivetti-Pezzi P
Mod Probl Ophthalmol; 1976; 16():314-23. PubMed ID: 55960
[TBL] [Abstract][Full Text] [Related]
56. [Cytostatic and immunosuppressive treatment of ocular Behçet syndrome].
Schilling H; Bornfeld N; Windeck R; Wessing A; Kirch W
Klin Monbl Augenheilkd; 1990 Feb; 196(2):62-9. PubMed ID: 2325343
[TBL] [Abstract][Full Text] [Related]
57. Comparison of patients with Behçet's disease in the 1980s and 1990s.
Yoshida A; Kawashima H; Motoyama Y; Shibui H; Kaburaki T; Shimizu K; Ando K; Hijikata K; Izawa Y; Hayashi K; Numaga J; Fujino Y; Masuda K; Araie M
Ophthalmology; 2004 Apr; 111(4):810-5. PubMed ID: 15051217
[TBL] [Abstract][Full Text] [Related]
58. [Pulmonary embolism and Behçet's disease].
Hammami S; Addad F; Kaoubaa N; Golli M; Chebbi W; Hamzaoui A; Hammami M; Ben Farhat M; Majhoub S
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):786-90. PubMed ID: 17067096
[TBL] [Abstract][Full Text] [Related]
59. [Behcet's disease. Experience of an internal medicine service from 1982 to 1991].
da Cunha RM; Horta AB; Castro AS
Acta Med Port; 1992 Dec; 5(11):571-4. PubMed ID: 1293948
[TBL] [Abstract][Full Text] [Related]
60. Immunosuppressive treatment of Behcet's disease.
Aoki K; Sugiura S
Mod Probl Ophthalmol; 1976; 16():309-13. PubMed ID: 1250236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
